Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Weinstock

Showing results (121-130 of 172) with videos related to

Pageof 18
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|June 14, 2017
Functional proteogenomics reveals biomarkers and therapeutic targets in lymphomasDelphine C M Rolland, Venkatesha Basrur, Yoon-Kyung Jeon, et al.
Blood Cancer Discovery|March 5, 2024
Acquired Multidrug Resistance in AML Is Caused by Low Apoptotic Priming in Relapsed MyeloblastsElyse A Olesinski, Karanpreet Singh Bhatia, Chuqi Wang, et al.
Cell Reports|May 26, 2015
Co-activation of AMPK and mTORC1 Induces Cytotoxicity in Acute Myeloid LeukemiaPierre Sujobert, Laury Poulain, Etienne Paubelle, et al.
Oncotarget|March 1, 2018
Inhibition of mTORC1/C2 signaling improves anti-leukemia efficacy of JAK/STAT blockade in <i>CRLF2</i> rearranged and/or <i>JAK</i> driven Philadelphia chromosome-like acute B-cell lymphoblastic leukemiaQi Zhang, Ce Shi, Lina Han, et al.
Blood|December 19, 2013
A targeted mutational landscape of angioimmunoblastic T-cell lymphomaOreofe Odejide, Oliver Weigert, Andrew A Lane, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2019
Chimeric Antigen Receptor T Cells Targeting CD79b Show Efficacy in Lymphoma with or without Cotargeting CD19Maria Ormhøj, Irene Scarfò, Maria L Cabral, et al.
Blood|August 25, 2021
Primary cytotoxic T-cell lymphomas harbor recurrent targetable alterations in the JAK-STAT pathwayKatie Lee, Mark G Evans, Lei Yang, et al.
Iscience|June 21, 2021
Combined epigenetic and metabolic treatments overcome differentiation blockade in acute myeloid leukemiaBarry M Zee, Kamrine E Poels, Cong-Hui Yao, et al.
Cell Reports|October 19, 2017
A B Cell Regulome Links Notch to Downstream Oncogenic Pathways in Small B Cell LymphomasRussell J H Ryan, Jelena Petrovic, Dylan M Rausch, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 15, 2024
Correction: Chimeric Antigen Receptor T Cells Targeting CD79b Show Efficacy in Lymphoma with or without Cotargeting CD19Maria Ormhøj, Irene Scarfò, Maria L Cabral, et al.
Pageof 18

Showing results (121-130 of 172) with videos related to

Sort By:
Pageof 18
Proceedings of the National Academy of Sciences of the United States of America|June 14, 2017
Functional proteogenomics reveals biomarkers and therapeutic targets in lymphomasDelphine C M Rolland, Venkatesha Basrur, Yoon-Kyung Jeon, et al.
Blood Cancer Discovery|March 5, 2024
Acquired Multidrug Resistance in AML Is Caused by Low Apoptotic Priming in Relapsed MyeloblastsElyse A Olesinski, Karanpreet Singh Bhatia, Chuqi Wang, et al.
Cell Reports|May 26, 2015
Co-activation of AMPK and mTORC1 Induces Cytotoxicity in Acute Myeloid LeukemiaPierre Sujobert, Laury Poulain, Etienne Paubelle, et al.
Oncotarget|March 1, 2018
Inhibition of mTORC1/C2 signaling improves anti-leukemia efficacy of JAK/STAT blockade in <i>CRLF2</i> rearranged and/or <i>JAK</i> driven Philadelphia chromosome-like acute B-cell lymphoblastic leukemiaQi Zhang, Ce Shi, Lina Han, et al.
Blood|December 19, 2013
A targeted mutational landscape of angioimmunoblastic T-cell lymphomaOreofe Odejide, Oliver Weigert, Andrew A Lane, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2019
Chimeric Antigen Receptor T Cells Targeting CD79b Show Efficacy in Lymphoma with or without Cotargeting CD19Maria Ormhøj, Irene Scarfò, Maria L Cabral, et al.
Blood|August 25, 2021
Primary cytotoxic T-cell lymphomas harbor recurrent targetable alterations in the JAK-STAT pathwayKatie Lee, Mark G Evans, Lei Yang, et al.
Iscience|June 21, 2021
Combined epigenetic and metabolic treatments overcome differentiation blockade in acute myeloid leukemiaBarry M Zee, Kamrine E Poels, Cong-Hui Yao, et al.
Cell Reports|October 19, 2017
A B Cell Regulome Links Notch to Downstream Oncogenic Pathways in Small B Cell LymphomasRussell J H Ryan, Jelena Petrovic, Dylan M Rausch, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 15, 2024
Correction: Chimeric Antigen Receptor T Cells Targeting CD79b Show Efficacy in Lymphoma with or without Cotargeting CD19Maria Ormhøj, Irene Scarfò, Maria L Cabral, et al.
Pageof 18